Uncategorized

BCAN Media Relations
Contact:
Mark Story
Vice President of Communications and Marketing
[email protected] | 301-215-9099 ext: 208

Media Relations Team:
[email protected]

FDA-BCAN Workshop

Co-sponsored by the: U.S. Food and Drug Administration (FDA) and the Bladder Cancer Advocacy Network (BCAN) Date:          Thursday, August 8, 2019 from Noon-4PM EST Location:   Capital… Read more

How does immunotherapy work?  Peter H. O’Donnell, MD, from The University of Chicago, Section of Hematology/Oncology, explains immunotherapy as a bladder cancer treatment and addresses… Read more

Expert Explanations

Leading bladder cancer experts have provided a more in-depth look at topics in which patients have expressed a greater interest.  Additional topics will be coming… Read more

Frequently Asked Questions

What is bladder cancer? Bladder cancer is the nation’s sixth most common form of cancer with more than 81,000 new cases and over 17,000 deaths each year. … Read more